Status:
WITHDRAWN
Prevention of P. Vivax Malaria During Pregnancy in Bolivia
Lead Sponsor:
Institut de Recherche pour le Developpement
Collaborating Sponsors:
Instituto Nacional de Laboratorios de Salud (INLASA)
Pan American Health Organization
Conditions:
Malaria
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine which, between weekly prophylaxis or malaria attack treatment, both by chloroquine, is the most appropriate way to protect women and foetus from P. vivax mala...
Detailed Description
It has been demonstrated that malaria is responsible for anaemia during pregnancy and reduces birth weight among newborns. In Bolivia, malaria is mostly caused by P. vivax. Maternal and foetal consequ...
Eligibility Criteria
Inclusion
- Pregnancy between 4 to 36 weeks of gestation
- Intention to deliver at the maternity clinics
- Residence near the maternity clinics
- Written informed consent (parents or tutors if aged\<18 years)
Exclusion
- Pregnancy prior to 4 weeks or after 36 weeks of gestation
- Allergy to chloroquine
- Clinical signs of hepatic or renal alteration
- Inability to take drugs by oral route
- Presence of effective uterine contractions
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00290420
Start Date
March 1 2006
End Date
November 1 2007
Last Update
May 22 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.